Literature DB >> 10942360

A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis.

P W Zandstra1, D A Lauffenburger, C J Eaves.   

Abstract

A major limitation to the widespread use of hematopoietic stem cells (HSC) is the relatively crude level of our knowledge of how to maintain these cells in vitro without loss of the long-term multilineage growth and differentiation properties required for their clinical utility. An experimental and theoretical framework for predicting and controlling the outcome of HSC stimulation by exogenous cytokines would thus be useful. An emerging theme from recent HSC expansion studies is that a net gain in HSC numbers requires the maintenance of critical signaling ligand(s) above a threshold level. These ligand-receptor complex thresholds can be maintained, for example, by high concentrations of soluble cytokines or by extracellular matrix- or cell-bound cytokine presentation. According to such a model, when the relevant ligand-receptor interaction falls below a critical level, the probability of a differentiation response is increased; otherwise, self-renewal is favored. Thus, in addition to the identity of a particular receptor-ligand interaction being important to the regulation of stem cell responses, the quantitative nature of this interaction, as well as the dynamics of receptor expression, internalization, and signaling, may have a significant influence on stem cell fate decisions. This review uses examples from hematopoiesis and other tissue systems to examine existing evidence for a role of receptor activation thresholds in regulating hematopoietic stem cell self-renewal versus differentiation events. (Blood. 2000;96:1215-1222)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942360

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  Stem cell heterogeneity: implications for aging and regenerative medicine.

Authors:  Christa E Muller-Sieburg; Hans B Sieburg; Jeff M Bernitz; Giulio Cattarossi
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  Elimination of fast variables in chemical Langevin equations.

Authors:  Yueheng Lan; Timothy C Elston; Garegin A Papoian
Journal:  J Chem Phys       Date:  2008-12-07       Impact factor: 3.488

3.  Towards predictive models of stem cell fate.

Authors:  Sowmya Viswanathan; Peter W Zandstra
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Primitive hematopoietic cells resist HIV-1 infection via p21.

Authors:  Jielin Zhang; David T Scadden; Clyde S Crumpacker
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

5.  Kinetic analysis of neurotrophin-3-mediated differentiation of embryonic stem cells into neurons.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

6.  Threshold levels of ERK activation for chemotactic migration differ for NGF and EGF in rat pheochromocytoma PC12 cells.

Authors:  W C Ho; S Uniyal; H Zhou; V L Morris; B M C Chan
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

Review 7.  Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science.

Authors:  Ji Sun Choi; Bhushan P Mahadik; Brendan A C Harley
Journal:  Biotechnol J       Date:  2015-09-10       Impact factor: 4.677

8.  Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.

Authors:  Antonella Rigo; Michele Gottardi; Alberto Zamò; Pierluigi Mauri; Massimiliano Bonifacio; Mauro Krampera; Ernesto Damiani; Giovanni Pizzolo; Fabrizio Vinante
Journal:  Mol Cancer       Date:  2010-10-14       Impact factor: 27.401

9.  Challenges and Opportunities to Harnessing the (Hematopoietic) Stem Cell Niche.

Authors:  Ji Sun Choi; Brendan A C Harley
Journal:  Curr Stem Cell Rep       Date:  2016-01-29

Review 10.  Cell cycle entry of hematopoietic stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors.

Authors:  Tao Cheng; David T Scadden
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.